24
2
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T9614 |
MERS-CoV-IN-1
|
SARS-CoV | Microbiology/Virology |
MERS-CoV-IN-1 对冠状病毒的活性具有优异的抑制作用,可用作预防冠状病毒引起疾病的药物组合物。 | |||
T7766 |
Remdesivir
瑞德西韦,GS-5734 |
SARS-CoV; DNA/RNA Synthesis | Cell Cycle/Checkpoint; DNA Damage/DNA Repair; Microbiology/Virology |
Remdesivir (GS-5734) 是一种核苷类似物,一种广谱的抗病毒化合物,通过抑制病毒的 RNA 依赖性 RNA 聚合酶发挥活性。Remdesivir 对埃博拉病毒、SARS 病毒、MERS病毒等均有活性,对 COVID-19 有潜在治疗价值。 | |||
T72231 |
SARS-CoV-2/MERS Mpro-IN-2
|
||
SARS-CoV-2/MERS Mpro-IN-2 是一种有效的 SARS-CoV-2和MERS 主要蛋白酶抑制剂,IC50值分别为 0.21, 0.07 µM。 | |||
T72230 |
SARS-CoV-2/MERS Mpro-IN-1
|
||
SARS-CoV-2/MERS Mpro-IN-1 是一种有效的SARS-CoV-2和MERS 主要蛋白酶抑制剂,IC50值分别为 0.10、0.06 µM。 | |||
T60951 |
Molnupiravir
EIDD-2801,Lagevrio,MK-4482 |
SARS-CoV; Influenza Virus | Microbiology/Virology |
Molnupiravir (MK-4482) (EIDD-2801) 是核糖核苷类似物 EIDD-1931 的异丙酯前体药物,具有口服生物利用度。Molnupiravir 可用于 COVID-19 ,季节性和流行性流感的研究,对多种冠状病毒和流感病毒具有广谱的抗病毒活性,例如,SARS-CoV-2,MERS-CoV,SARS-CoV。 | |||
T60085 |
MM3122
GTPL11533,MM-3122,Ac-GQFR-kbt |
SARS-CoV | Microbiology/Virology |
MM3122 (MM-3122) 是一种选择性的 II 型跨膜丝氨酸蛋白酶 (TMPRSS2) 抑制剂,IC50为 0.34 nM。MM3122 可以有效阻断 TMPRSS2,从而抑制 SARS-CoV-2 和 MERS-CoV 进入人类细胞。 | |||
T8498 |
EIDD-1931
Beta-d-N4-hydroxycytidine |
Virus Protease; HCV Protease; SARS-CoV; Topoisomerase | DNA Damage/DNA Repair; Microbiology/Virology; Proteases/Proteasome |
EIDD-1931 (Beta-d-N4-hydroxycytidine) 是一种核苷类抗病毒试剂 ,可抑制丙型肝炎病毒、基孔肯亚病毒和委内瑞拉马脑炎病毒的复制活性。 | |||
T6573 |
E 64c
阿洛司他丁酸,NSC 694279,EP 475,Loxistatin Acid |
SARS-CoV; Cysteine Protease | Microbiology/Virology; Proteases/Proteasome |
E 64c (EP 475) 是一种不可逆且可透过膜的半胱氨酸蛋白酶抑制剂,是 E-64 的衍生物。它也是钙离子激活中性蛋白酶抑制剂和组织蛋白酶 C 弱不可逆抑制剂,可抑制 MERS-CoV。 | |||
T36652 |
Anti-MERS-3A1 mAb
Anti-MERS-3A1 mAb |
||
Anti-MERS-3A1 mAb (MERS-3A1) is a high-affinity human monoclonal IgG1 antibody derived from CHO cells. It effectively inhibits the interaction between the MERS-CoV spike protein and the DPP4 receptor[1]. | |||
T12836 |
SARS-CoV-2-IN-1
|
Others | Others |
SARS-CoV-2-IN-1 is a potent inhibitor of Mpro(SARS-CoV-2 Mpro, SARS-CoV Mpro and MERS-CoV Mpro with IC50s of 0.67, 0.90 and 0.58 μM, respectively). | |||
T68674 |
Vincapusine
|
||
Vincapusine is a natural inhibitor of 3C-like protease (3CLpro), targeting SARS-CoV-2 3CLpro, SARS-CoV 3CLpro and MERS-CoV 3CLpro. | |||
T39334 |
Remdesivir nucleoside monophosphate
|
||
Remdesivir nucleoside monophosphate, a metabolite of Remdesivir, is a potent antiviral compound with nucleoside analogue characteristics. It exhibits effective antiviral activity against both SARS-CoV and MERS-CoV. | |||
T70451 |
Blancoxanthone
|
||
Blancoxanthone is a molecule isolated from plants could also be potential drug candidates against COVID-19. Moreover, these could also show promising inhibitory effects against influenza-parainfluenza viruses, respiratory syncytial virus, severe acute respiratory syndrome (SARS), and Middle East respiratory syndrome coronavirus (MERS-CoV). | |||
T72312 | SARS-CoV-2 3CLpro-IN-10 | ||
SARS-CoV-2 3CLpro-IN-10(5d)为一种有效的抗 SARS-CoV-2 3CL 蛋白酶抑制剂,其IC50值仅为190 nM,同时对SARS-CoV-1的IC50值为790 nM,对MERS-CoV的IC50值则为70 nM,显示出广谱的抗病毒活性。 | |||
T78867 | WU-04 | SARS-CoV | Microbiology/Virology |
WU-04为针对SARS-CoV-2的3CLpro蛋白的非共价抑制剂,对包括Alpha、Beta、Gamma、Delta、Lambda和Omicron在内的6种SARS-CoV-2变体及SARS-CoV与MERS-CoV的3CLpro蛋白展现出高效的抑制作用。 | |||
T38174 | Mpro inhibitor N3 hemihydrate | ||
Mpro inhibitor N3 hemihydrate is a potent inhibitor of SARS-CoV-2 Mpro with an EC50 of 16.77 μM for SARS-CoV-2. Mpro inhibitor N3 hemihydrate specifically inhibits Mpro from multiple coronaviruses, including SARS-CoV and MERS-CoV. Mpro inhibitor N3 hemihydrate displays inhibition against HCoV-229E, FIPV, and MHV-A59 with individual IC50 of 4.0 μM, 8.8 μM, and 2.7 μM, respectively[1][2]. Mpro inhibitor N3 hemihydrate (0-0.64 μM) is able to penetrate cells to inhibit the replication of IBV viruses... | |||
T76669 | Anti-MERS-D12 mAb | ||
Anti-MERS-D12 mAb (MERS-D12; MERS Antibody-D12) 是一种IgG1类人源单克隆抗体,与MERS-CoV Spike蛋白的二聚体结构中的受体结合域(RBD)上的DPP4相互作用区直接结合,实现通过阻断受体结合的方式达到中和效果。 | |||
T72313 | SARS-CoV-2 3CLpro-IN-11 | ||
SARS-CoV-2 3CLpro-IN-11(11d)为一种针对SARS-CoV-2 3CL蛋白酶的有效抑制剂,具备IC50值140 nM,并对SARS-CoV-1和MERS-CoV分别展现出IC50值240 nM与70 nM的抑制活性,显示出其广谱的抗病毒能力。 | |||
T79339 |
NSC89641
|
SARS-CoV | Microbiology/Virology |
NSC89641对MERS-CoV Mpro和SARS-CoV-2 Mpro均显示出显著的抑制作用,其IC50值分别小于3.5 μM和为3.05 μM,表明NSC89641对这两种冠状病毒主要蛋白酶具有较高的选择性抑制效力。 | |||
T69547 | UAWJ9-36-3 | ||
UAWJ9-36-3 is a SARS-CoV-2 Protease inhibitor (IC50 = 54 nM). UAWJ9-36-3 showed potent binding and enzymatic inhibition against the Mpro's from SARS-CoV-2, SARS-CoV, MERS-CoV, HCoV-OC43, HCoV-NL63, HCoV-229E, and HCoV-HKU1. UAWJ9-36-3 is a promising candidate to be further developed as a broad-spectrum coronavirus antiviral. | |||
T69548 |
UAWJ9-36-1
|
||
UAWJ9-36-1 is a SARS-CoV-2 Protease inhibitor (IC50 = 51 nM). UAWJ9-36-1 showed potent binding and enzymatic inhibition against the Mpro's from SARS-CoV-2, SARS-CoV, MERS-CoV, HCoV-OC43, HCoV-NL63, HCoV-229E, and HCoV-HKU1. UAWJ9-36-1 is a promising candidate to be further developed as a broad-spectrum coronavirus antiviral. | |||
T73973 | Imatinib Impurity E | ||
Imatinib Impurity E 是 Imatinib 的杂质。Imatinib 是一种口服生物可用的酪氨酸激酶抑制剂,可选择性抑制 BCR/ABL,v-Abl,PDGFR,c-kit 激酶活性。Imatinib (STI571) 靠近 ATP 结合位点结合,将其锁定在封闭或自我抑制的构象中,因此半竞争性抑制蛋白质的酶活性。Imatinib 还抑制 SARS-CoV 和MERS-CoV。 | |||
T74467 |
Remdesivir de(ethylbutyl 2-aminopropanoate)
|
||
Remdesivir de(ethylbutyl 2-aminopropanoate) 是 Remdesivir 的一种杂质,后者为一种具有抗病毒活性的核苷类似物。在 HAE 细胞针对 SARS-CoV 和 MERS-CoV 的实验中,Remdesivir 的 EC50 值为 74 nM;在针对鼠肝炎病毒的延迟脑肿瘤细胞实验中,其 EC50 值为 30 nM。此外,Remdesivir 亦被认为具有针对 2019-nCoV (COVID-19) 的研究潜力。 | |||
T68485 | Apilimod HCl | ||
Apilimod dimesylate is a potent and selective PIKfyve inhibitor. It exhibits no significant activity at other lipid kinases and protein kinases, including PIP4K, PIP5K, mTOR, PI3K and PI4K. Apilimod dimesylate inhibits cellular entry by SARS-CoV-2, MERS-CoV and MHV S pseudovirions. It reduces the number of SARS-CoV-2-infected hiPSC-derived pneumocyte-like cells by 85% and inhibits SARS-CoV-2 replication in donor lung tissue. It also exhibits selective cytotoxicity in B-cell non-Hodgkin lymphoma ... |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T3374 |
Dihydrotanshinone I
DHTS,15,16-dihydrotanshinone I,二氢丹参酮I,二氢丹参酮 I |
SARS-CoV; ROS | Immunology/Inflammation; Microbiology/Virology |
Dihydrotanshinone I (DHTS) 是从丹参中分离到的一种天然产物,可抑制 MERS-CoV,可研究心血管疾病。 | |||
TN3528 |
Bonducellpin D
|
Antifection | Microbiology/Virology |
Bonducellpin D may show inhibitory activities on the Para3 virus. It also exhibits moderate activity against four tested human cancer cell lines, HepG-2, K562, HeLa, and Du145. |